Posts With Tag ophthalmology

Oculis Holding AG reports strong cash position and promising Phase 2 ACUITY trial results for OCS-05, indicating potential market opportunities in treating acute optic neuritis.

Explore Outlook Therapeutics, Inc.'s (OTLK) latest financial report revealing significant losses and liquidity concerns. Key insights on R&D, debt, and clinical trial prospects.